Share Price, page-3825

I think most are aware of what could 'potentially' eventuate - if a swag of successive inflection points are ticked off.

I prefer to climb the ladder one rung at a time using the last rung achieved as a metric to estimations of the next rung.

Our next rung is PDUFA approval for Trof. This is basically a double rung as ROW is virtually guaranteed following approval.

The next 12 trading days are the most critical in the history of this company. Trof marketing approval will remove NEUREN from the speculative tag to a significant income generating entity. Those who hold fast through this period will increase their current paper profits without further risk and be in a position to hold shares in a derisked ASX200 company whose tradjectory will likely be upwards. (How good is that?) I don't want to think about the other side of this penny, a penny which is extremely heavily weighted to land heads up.

In spite of that, anyone who is not at least slightly nervous about the next 12 trading days is a gambler extraordinaire.